US Stock MarketDetailed Quotes

Serina Therapeutics (SER)

Watchlist
  • 1.970
  • +0.030+1.55%
Close Apr 24 16:00 ET
  • 1.970
  • 0.0000.00%
Post 20:01 ET
24.26MMarket Cap-1.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Serina Therapeutics (SER) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.77%-17.96M
-31.47%-6.03M
-29.98%-3.85M
53.18%-3.75M
-174.06%-4.32M
-592.12%-17.14M
-3,892.56%-4.59M
-189.26%-2.96M
-826.97%-8.01M
-122.43%-1.58M
Net income from continuing operations
-71.46%-19.22M
-21.22%-3.34M
-432.25%-4.6M
-224.82%-6.46M
67.89%-4.82M
-312.70%-11.21M
-361.85%-2.75M
-21.06%1.38M
540.72%5.18M
-1,005.61%-15.02M
Operating gains losses
64.05%-4.73M
-5.74%-2.93M
73.50%-1.77M
110.29%956K
-117.73%-989K
-1,121.54%-13.16M
-15,294.44%-2.77M
-1,018.96%-6.67M
-3,093.81%-9.29M
3,343.02%5.58M
Depreciation and amortization
-62.37%73K
-57.14%24K
-71.43%16K
-71.93%16K
-32.00%17K
115.56%194K
833.33%56K
3.70%56K
235.29%57K
92.31%25K
Other non cash items
-11.14%654K
461.29%348K
53.03%101K
-61.90%144K
-73.48%61K
0.55%736K
-70.62%62K
-84.69%66K
759.09%378K
400.00%230K
Change In working capital
144.33%1.47M
-531.98%-1.09M
26.22%1.4M
114.75%706K
-14.95%455K
-4,193.83%-3.32M
31.20%-172K
2,226.92%1.11M
-4,657.14%-4.79M
92.45%535K
-Change in receivables
--0
--0
----
----
----
--65K
--14K
--36K
----
----
-Change in prepaid assets
135.31%673K
-126.34%-143K
233.04%766K
84.44%-408K
903.51%458K
-12,012.50%-1.91M
3,778.57%543K
22,900.00%230K
---2.62M
-5,800.00%-57K
-Change in payables and accrued expense
176.61%966K
-9.25%-744K
5.38%862K
138.88%795K
-91.81%53K
-598.42%-1.26M
-227.40%-681K
13,733.33%818K
-1,500.68%-2.05M
101.56%647K
-Change in other current liabilities
21.03%-169K
-316.67%-200K
-3,414.29%-232K
370.34%319K
-1.82%-56K
-13.83%-214K
14.29%-48K
114.89%7K
-187.80%-118K
-25.00%-55K
Cash from discontinued investing activities
Operating cash flow
-4.77%-17.96M
-31.47%-6.03M
-29.98%-3.85M
53.18%-3.75M
-174.06%-4.32M
-592.12%-17.14M
-3,892.56%-4.59M
-189.26%-2.96M
-826.97%-8.01M
-122.43%-1.58M
Investing cash flow
Cash flow from continuing investing activities
-168.18%-59K
0
-333.33%-13K
-46K
0
95.63%-22K
92.86%-5K
97.48%-3K
0
-14K
Net PPE purchase and sale
-168.18%-59K
--0
-333.33%-13K
---46K
--0
95.63%-22K
92.86%-5K
97.48%-3K
--0
---14K
Cash from discontinued investing activities
Investing cash flow
-168.18%-59K
--0
-333.33%-13K
---46K
--0
95.63%-22K
92.86%-5K
97.48%-3K
--0
---14K
Financing cash flow
Cash flow from continuing financing activities
31.79%17.41M
-90.44%481K
7,393.02%6.44M
3.78%5.57M
80.24%4.92M
31.24%13.21M
38,800.00%5.03M
4,200.00%86K
48,890.91%5.37M
-72.96%2.73M
Net issuance payments of debt
70.89%4.91M
--0
--4.91M
--0
--0
-71.40%2.88M
938.46%109K
--0
3,258.33%379K
-76.34%2.39M
Net common stock issuance
50.88%7.54M
-90.48%476K
--1.52M
--629K
--4.92M
--5M
--5M
--0
--0
--0
Net preferred stock issuance
--4.94M
--0
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-99.70%15K
106.41%5K
-90.70%8K
-99.98%1K
-75.00%1K
33,233.33%5M
---78K
514.29%86K
498,700.00%4.99M
--4K
Net other financing activities
----
----
----
----
----
--337K
--0
--0
--0
--337K
Cash from discontinued financing activities
Financing cash flow
31.79%17.41M
-90.44%481K
7,393.02%6.44M
3.78%5.57M
80.24%4.92M
31.24%13.21M
38,800.00%5.03M
4,200.00%86K
48,890.91%5.37M
-72.96%2.73M
Net cash flow
Beginning cash position
-51.80%3.67M
166.46%8.62M
-1.19%6.04M
-51.27%4.27M
-51.80%3.67M
1,332.14%7.62M
-57.33%3.24M
-29.90%6.11M
-11.66%8.76M
1,332.14%7.62M
Current changes in cash
84.75%-602K
-1,370.02%-5.55M
189.58%2.58M
167.15%1.77M
-47.67%595K
-155.69%-3.95M
1,050.00%437K
-152.32%-2.88M
-122.02%-2.64M
-87.88%1.14M
Effect of exchange rate changes
---14K
----
----
----
----
--0
----
----
----
----
End cash Position
-16.78%3.06M
-16.78%3.06M
166.46%8.62M
-1.19%6.04M
-51.27%4.27M
-51.80%3.67M
-51.80%3.67M
-57.33%3.24M
-29.90%6.11M
-11.66%8.76M
Free cash flow
-4.98%-18.01M
-31.32%-6.03M
-30.29%-3.86M
52.60%-3.8M
-171.65%-4.32M
-475.81%-17.16M
-9,107.84%-4.59M
-159.41%-2.97M
-579.30%-8.01M
-124.40%-1.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.77%-17.96M-31.47%-6.03M-29.98%-3.85M53.18%-3.75M-174.06%-4.32M-592.12%-17.14M-3,892.56%-4.59M-189.26%-2.96M-826.97%-8.01M-122.43%-1.58M
Net income from continuing operations -71.46%-19.22M-21.22%-3.34M-432.25%-4.6M-224.82%-6.46M67.89%-4.82M-312.70%-11.21M-361.85%-2.75M-21.06%1.38M540.72%5.18M-1,005.61%-15.02M
Operating gains losses 64.05%-4.73M-5.74%-2.93M73.50%-1.77M110.29%956K-117.73%-989K-1,121.54%-13.16M-15,294.44%-2.77M-1,018.96%-6.67M-3,093.81%-9.29M3,343.02%5.58M
Depreciation and amortization -62.37%73K-57.14%24K-71.43%16K-71.93%16K-32.00%17K115.56%194K833.33%56K3.70%56K235.29%57K92.31%25K
Other non cash items -11.14%654K461.29%348K53.03%101K-61.90%144K-73.48%61K0.55%736K-70.62%62K-84.69%66K759.09%378K400.00%230K
Change In working capital 144.33%1.47M-531.98%-1.09M26.22%1.4M114.75%706K-14.95%455K-4,193.83%-3.32M31.20%-172K2,226.92%1.11M-4,657.14%-4.79M92.45%535K
-Change in receivables --0--0--------------65K--14K--36K--------
-Change in prepaid assets 135.31%673K-126.34%-143K233.04%766K84.44%-408K903.51%458K-12,012.50%-1.91M3,778.57%543K22,900.00%230K---2.62M-5,800.00%-57K
-Change in payables and accrued expense 176.61%966K-9.25%-744K5.38%862K138.88%795K-91.81%53K-598.42%-1.26M-227.40%-681K13,733.33%818K-1,500.68%-2.05M101.56%647K
-Change in other current liabilities 21.03%-169K-316.67%-200K-3,414.29%-232K370.34%319K-1.82%-56K-13.83%-214K14.29%-48K114.89%7K-187.80%-118K-25.00%-55K
Cash from discontinued investing activities
Operating cash flow -4.77%-17.96M-31.47%-6.03M-29.98%-3.85M53.18%-3.75M-174.06%-4.32M-592.12%-17.14M-3,892.56%-4.59M-189.26%-2.96M-826.97%-8.01M-122.43%-1.58M
Investing cash flow
Cash flow from continuing investing activities -168.18%-59K0-333.33%-13K-46K095.63%-22K92.86%-5K97.48%-3K0-14K
Net PPE purchase and sale -168.18%-59K--0-333.33%-13K---46K--095.63%-22K92.86%-5K97.48%-3K--0---14K
Cash from discontinued investing activities
Investing cash flow -168.18%-59K--0-333.33%-13K---46K--095.63%-22K92.86%-5K97.48%-3K--0---14K
Financing cash flow
Cash flow from continuing financing activities 31.79%17.41M-90.44%481K7,393.02%6.44M3.78%5.57M80.24%4.92M31.24%13.21M38,800.00%5.03M4,200.00%86K48,890.91%5.37M-72.96%2.73M
Net issuance payments of debt 70.89%4.91M--0--4.91M--0--0-71.40%2.88M938.46%109K--03,258.33%379K-76.34%2.39M
Net common stock issuance 50.88%7.54M-90.48%476K--1.52M--629K--4.92M--5M--5M--0--0--0
Net preferred stock issuance --4.94M--0--0----------0--0--0--------
Proceeds from stock option exercised by employees -99.70%15K106.41%5K-90.70%8K-99.98%1K-75.00%1K33,233.33%5M---78K514.29%86K498,700.00%4.99M--4K
Net other financing activities ----------------------337K--0--0--0--337K
Cash from discontinued financing activities
Financing cash flow 31.79%17.41M-90.44%481K7,393.02%6.44M3.78%5.57M80.24%4.92M31.24%13.21M38,800.00%5.03M4,200.00%86K48,890.91%5.37M-72.96%2.73M
Net cash flow
Beginning cash position -51.80%3.67M166.46%8.62M-1.19%6.04M-51.27%4.27M-51.80%3.67M1,332.14%7.62M-57.33%3.24M-29.90%6.11M-11.66%8.76M1,332.14%7.62M
Current changes in cash 84.75%-602K-1,370.02%-5.55M189.58%2.58M167.15%1.77M-47.67%595K-155.69%-3.95M1,050.00%437K-152.32%-2.88M-122.02%-2.64M-87.88%1.14M
Effect of exchange rate changes ---14K------------------0----------------
End cash Position -16.78%3.06M-16.78%3.06M166.46%8.62M-1.19%6.04M-51.27%4.27M-51.80%3.67M-51.80%3.67M-57.33%3.24M-29.90%6.11M-11.66%8.76M
Free cash flow -4.98%-18.01M-31.32%-6.03M-30.29%-3.86M52.60%-3.8M-171.65%-4.32M-475.81%-17.16M-9,107.84%-4.59M-159.41%-2.97M-579.30%-8.01M-124.40%-1.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -